Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Xtant Medical Holdings, Inc.

AMEX: XTNTHealthcare / Drugs - Generic / Montana, U.S.A
3.04+0.2400+8.57%Vol 1 3341Y Perf -62.88%
Mar 26th, 2019 10:36
BID2.96 ASK3.04
Open2.85 Previous Close2.80
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.00 
Analyst Rating
Strong Buy 1.00
Potencial %
97.37 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★+     49.32
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     42.10
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)40 
Earnings Rating
Neutral
Price Range Ratio 52wk %
19.64 
Earnings Date
27th Mar 2019

Today's Price Range

2.853.04

 

52wk Range

1.618.89

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-22.44%
3 Months
12.90%
6 Months
-30.00%
1 Year
-62.88%
3 Years
-90.67%
5 Years
-97.19%

Name / TickerPriceChg.Chg.%
XTNT3.040.24008.57
AAPL191.392.65001.40
GOOG1 191.14-1.8600-0.16
MSFT117.660.00000.00
XOM80.991.07001.34
WFC48.490.41000.85
JNJ139.112.50001.83
FB168.302.01001.21
GE10.020.14001.42
JPM99.170.24000.24
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.40
Current Ratio
3.60
Long Term Debt to Total Capital
0.86
Total Debt to Equity
6.06
Interest Coverage
-2.40
Leverage Ratio 7.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
63.50
EBIT Margin
-40.30
EBITDA Margin
-32.20
Pre-tax Profit Margin
-42.30
Profit Margin
-25.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
53 622
Revenue per Share
4.07
Revenue Growth 3 Years
0.54
Revenue Growth 5 Years
18.58

Earnings HistoryEstimateReportedSurprise %
Q02 2017--0.54-
Q01 2017--0.29-
Q04 2016-0.13-0.31-138.46
Q03 2016-0.32-0.40-25.00
Q02 2016-0.40-0.377.50
Q01 2016-0.45-0.47-4.44
Q04 2015-0.04-0.41-925.00
Q03 2015-0.15-0.51-240.00
Earnings Per EndEstimateRevision %Trend
12/2016 QR-0.1335.00Positive
3/2017 QR-0.0950.00Positive
12/2017 FY-0.940.00-
12/2018 FY-0.100.00-
Next Report Date27th Mar 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1 334
Shares Outstanding (in ths.)13 171
Trades Count10
Dollar Volume3 889
Avg. Volume13 049
Avg. Weekly Volume10 487
Avg. Monthly Volume17 517
Avg. Quarterly Volume13 769

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

45%55%

Bearish Bullish

68%32%

Bearish Bullish

56%44%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News